Literature DB >> 20220773

Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo.

S Landmeier, B Altvater, S Pscherer, J Meltzer, N Sebire, M Pule, J Vera, M Hotfilder, H Juergens, J Vormoor, C Rossig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20220773     DOI： 10.1038/leu.2010.38

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  [Adoptive T-cell therapy of rhabdomyosarcoma].

Authors:  K Simon-Keller; A Paschen; S Eichmüller; S Gattenlöhner; S Barth; E Koscielniak; I Leuschner; P Stöbel; A Hombach; H Abken; A Marx
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

2.  Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo.

Authors:  A Bister; T Ibach; C Haist; G Gerhorst; D Smorra; M Soldierer; K Roellecke; M Wagenmann; K Scheckenbach; N Gattermann; C Wiek; H Hanenberg
Journal:  Mol Ther Oncolytics       Date:  2022-06-06       Impact factor: 6.311

Review 3.  New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future.

Authors:  Ettore Biagi; Virna Marin; Greta Maria Paola Giordano Attianese; Irene Pizzitola; Sarah Tettamanti; Elisabetta Cribioli; Andrea Biondi
Journal:  Ital J Pediatr       Date:  2011-09-22       Impact factor: 2.638

4.  Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia.

Authors:  Craig A Portell; Candice M Wenzell; Anjali S Advani
Journal:  Clin Pharmacol       Date:  2013-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.